Evaluation of malignancy-risk gene signature in breast cancer patients

Breast Cancer Research and Treatment

Volumn 120, Issue 1, 2010, Pages 25-34

  Chen, Dung Tsa ^a   Nasir, Aejaz ^a   Venkataramu, Chinnambally ^a   Fulp, William ^a   Gruidl, Mike ^a   Yeatman, Timothy ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Gene signature; Histologically normal tissue; Malignancy risk

Indexed keywords

ARTICLE; BREAST; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; EARLY CANCER; GENETIC ANALYSIS; GENETIC RISK; HISTOLOGY; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR GENE; TUMOR GROWTH;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 74849119764     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0357-6     Document Type: Article

References (9)

1. Chen D-T, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R et al (2009) Proliferative genes dominate malignancy-risk signature in histologically normal breast tissue. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0344-y
2. E Bair R Tibshirani 2004 Semi-supervised methods to predict patient survival from gene expression data PLoS Biol 2 4 E108 10.1371/journal.pbio. 0020108 10.1371/journal.pbio.0020108 15094809 (Pubitemid 39234509)
3. Miller RG (1981) Simultaneous statistical inference. Springer, New York
4. G Turashvili J Bouchal K Baumforth W Wei M Dziechciarkova J Ehrmann J Klein E Fridman J Skarda J Srovnal M Hajduch P Murray Z Kolar 2007 Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis BMC Cancer 7 55 10.1186/1471-2407-7-55 17389037 (Pubitemid 46605012)
5. M Chanrion V Negre H Fontaine N Salvetat F Bibeau G Mac Grogan, et al. 2008 A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer Clin Cancer Res 14 6 1744 1752 10.1158/1078-0432.CCR-07-1833 10.1158/1078-0432.CCR-07-1833 1:CAS:528: DC%2BD1cXjtlejtbs%3D 18347175
6. XJ Ma R Salunga JT Tuggle J Gaudet E Enright P McQuary, et al. 2003 Gene expression profiles of human breast cancer progression Proc Natl Acad Sci USA 100 10 5974 5979 10.1073/pnas.0931261100 10.1073/pnas.0931261100 1:CAS:528:DC%2BD3sXjvFOlt78%3D 12714683 (Pubitemid 36576916)
7. MJ van de Vijver YD He LJ van 't Veer H Dai AAM Hart DW Voskuil, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 25 1999 2009 10.1056/NEJMoa021967 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
8. Y Wang JG Klijn Y Zhang AM Sieuwerts MP Look F Yang, et al. 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 9460 671 679 1:CAS:528:DC%2BD2MXhsVOitLk%3D 15721472
9. E Huang SH Cheng H Dressman J Pittman MH Tsou CF Horng, et al. 2003 Gene expression predictors of breast cancer outcomes Lancet 361 9369 1590 1596 10.1016/S0140-6736(03)13308-9 10.1016/S0140-6736(03)13308-9 1:CAS:528: DC%2BD3sXjs1Wltbo%3D 12747878 (Pubitemid 36578995)